Huang et al., 2016 - Google Patents
Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharideHuang et al., 2016
View PDF- Document ID
- 606675253118727052
- Author
- Huang H
- Liu X
- Lv S
- Zhong W
- Zhang F
- Linhardt R
- Publication year
- Publication venue
- Applied microbiology and biotechnology
External Links
Snippet
Heparosan, the capsular polysaccharide of Escherichia coli K5 having a carbohydrate backbone similar to that of heparin, has become a potential precursor for bioengineering heparin. In the heparosan biosynthesis pathway, the gene waaR encoding α-1-, 2 …
- 241000588724 Escherichia coli 0 title abstract description 65
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor | |
Bhaskar et al. | Engineering of routes to heparin and related polysaccharides | |
Sze et al. | Biotechnological production of hyaluronic acid: a mini review | |
Boeriu et al. | Production methods for hyaluronan | |
Suflita et al. | Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering | |
Lindahl et al. | Generation of “Neoheparin” from E. c oli K5 Capsular Polysaccharide | |
Zhang et al. | Metabolic engineering of Escherichia coli BL21 for biosynthesis of heparosan, a bioengineered heparin precursor | |
Kang et al. | Bio-based strategies for producing glycosaminoglycans and their oligosaccharides | |
Shi et al. | Chondroitin sulfate: Extraction, purification, microbial and chemical synthesis | |
Karlsson et al. | Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates | |
US10704068B2 (en) | Method of producing heparan sulfate having anticoagulant activity | |
Schilling et al. | Metabolic engineering for production of functional polysaccharides | |
Vaidyanathan et al. | Engineered heparins as new anticoagulant drugs | |
Chen et al. | Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5 | |
Yu et al. | Chemoenzymatic quantification for monitoring unpurified polysaccharide in rich medium | |
Zhao et al. | A strategy for the synthesis of low-molecular-weight welan gum by eliminating capsule form of Sphingomonas strains | |
Datta et al. | High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification | |
Cimini et al. | Engineering S. equi subsp. zooepidemicus towards concurrent production of hyaluronic acid and chondroitin biopolymers of biomedical interest | |
Lin et al. | Purification and sequence characterization of chondroitin sulfate and dermatan sulfate from fishes | |
Dhurandhare et al. | Synthesis of 3-O-sulfated disaccharide and tetrasaccharide standards for compositional analysis of heparan sulfate | |
Deng et al. | Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies | |
Yu et al. | Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei | |
Yu et al. | Chromosome evolution of Escherichia coli Nissle 1917 for high‐level production of heparosan | |
Ma et al. | Design and construction of a Bacillus amyloliquefaciens cell factory for hyaluronic acid synthesis from Jerusalem artichoke inulin | |
Zhang et al. | Enzymatic production of chondroitin oligosaccharides and its sulfate derivatives |